SIRT1 and diabetes mellitus: Diabetes, on the other hand, decreased brain NAD+ levels and administration of NMN compensated for the loss of brain NAD+ and thereby prevented diabetic cognitive impairment and diabetes-induced loss of hippocampal neurons that paralleled preservation of mitochondrial bioenergetic function and activation of the SIRT1 pathway.